Global and China Autoimmune Disease Diagnostics Market Size, Status and Forecast 2020-2026

Publisher Name :
Date: 09-Oct-2020
No. of pages: 134
Inquire Before Buying

Global Autoimmune Disease Diagnostics Scope and Market Size

Autoimmune Disease Diagnostics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Autoimmune Disease Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Market segment by Type, the product can be split into

- Analyzers

- Assay Kits

Market segment by Application, split into

- Hospitals

- Diagnostic and Research Laboratories

Based on regional and country-level analysis, the Autoimmune Disease Diagnostics market has been segmented as follows:

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia-Pacific

- Latin America

- - Mexico

- - Brazil

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global Autoimmune Disease Diagnostics market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.

The key players covered in this study

- Abbott Laboratories

- Beckman Coulter

- Bio-Rad Laboratories

- EUROIMMUN

- Inova Diagnostics

- Roche Diagnostics

- Siemens Healthcare

- DiaSorin

- ERBA Diagnostics

- Euro Diagnostica

- Autoimmune Technologies

- Avant Diagnostics

- Exagen Diagnostics

- Gold Standard Diagnostics

- HOB Diagnostics

- HUMAN Diagnostics

- Immco Diagnostics

- ImmunArray

- Myriad Genetics

- Omega Diagnostics

- ORGENTEC Diagnostika

- Phadia

- Protagen

Global and China Autoimmune Disease Diagnostics Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Autoimmune Disease Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Analyzers
1.2.3 Assay Kits
1.3 Market by Application
1.3.1 Global Autoimmune Disease Diagnostics Market Share by Application: 2020 VS 2026
1.3.2 Hospitals
1.3.3 Diagnostic and Research Laboratories
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Autoimmune Disease Diagnostics Market Perspective (2015-2026)
2.2 Global Autoimmune Disease Diagnostics Growth Trends by Regions
2.2.1 Autoimmune Disease Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Autoimmune Disease Diagnostics Historic Market Share by Regions (2015-2020)
2.2.3 Autoimmune Disease Diagnostics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Autoimmune Disease Diagnostics Players by Market Size
3.1.1 Global Top Autoimmune Disease Diagnostics Players by Revenue (2015-2020)
3.1.2 Global Autoimmune Disease Diagnostics Revenue Market Share by Players (2015-2020)
3.2 Global Autoimmune Disease Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Autoimmune Disease Diagnostics Revenue
3.4 Global Autoimmune Disease Diagnostics Market Concentration Ratio
3.4.1 Global Autoimmune Disease Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Autoimmune Disease Diagnostics Revenue in 2019
3.5 Key Players Autoimmune Disease Diagnostics Area Served
3.6 Key Players Autoimmune Disease Diagnostics Product Solution and Service
3.7 Date of Enter into Autoimmune Disease Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Autoimmune Disease Diagnostics Breakdown Data by Type (2015-2026)
4.1 Global Autoimmune Disease Diagnostics Historic Market Size by Type (2015-2020)
4.2 Global Autoimmune Disease Diagnostics Forecasted Market Size by Type (2021-2026)
5 Autoimmune Disease Diagnostics Breakdown Data by Application (2015-2026)
5.1 Global Autoimmune Disease Diagnostics Historic Market Size by Application (2015-2020)
5.2 Global Autoimmune Disease Diagnostics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Autoimmune Disease Diagnostics Market Size (2015-2026)
6.2 North America Autoimmune Disease Diagnostics Market Size by Type (2015-2020)
6.3 North America Autoimmune Disease Diagnostics Market Size by Application (2015-2020)
6.4 North America Autoimmune Disease Diagnostics Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Autoimmune Disease Diagnostics Market Size (2015-2026)
7.2 Europe Autoimmune Disease Diagnostics Market Size by Type (2015-2020)
7.3 Europe Autoimmune Disease Diagnostics Market Size by Application (2015-2020)
7.4 Europe Autoimmune Disease Diagnostics Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Autoimmune Disease Diagnostics Market Size (2015-2026)
8.2 China Autoimmune Disease Diagnostics Market Size by Type (2015-2020)
8.3 China Autoimmune Disease Diagnostics Market Size by Application (2015-2020)
8.4 China Autoimmune Disease Diagnostics Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Autoimmune Disease Diagnostics Market Size (2015-2026)
9.2 Japan Autoimmune Disease Diagnostics Market Size by Type (2015-2020)
9.3 Japan Autoimmune Disease Diagnostics Market Size by Application (2015-2020)
9.4 Japan Autoimmune Disease Diagnostics Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Autoimmune Disease Diagnostics Market Size (2015-2026)
10.2 Southeast Asia Autoimmune Disease Diagnostics Market Size by Type (2015-2020)
10.3 Southeast Asia Autoimmune Disease Diagnostics Market Size by Application (2015-2020)
10.4 Southeast Asia Autoimmune Disease Diagnostics Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Autoimmune Disease Diagnostics Introduction
11.1.4 Abbott Laboratories Revenue in Autoimmune Disease Diagnostics Business (2015-2020))
11.1.5 Abbott Laboratories Recent Development
11.2 Beckman Coulter
11.2.1 Beckman Coulter Company Details
11.2.2 Beckman Coulter Business Overview
11.2.3 Beckman Coulter Autoimmune Disease Diagnostics Introduction
11.2.4 Beckman Coulter Revenue in Autoimmune Disease Diagnostics Business (2015-2020)
11.2.5 Beckman Coulter Recent Development
11.3 Bio-Rad Laboratories
11.3.1 Bio-Rad Laboratories Company Details
11.3.2 Bio-Rad Laboratories Business Overview
11.3.3 Bio-Rad Laboratories Autoimmune Disease Diagnostics Introduction
11.3.4 Bio-Rad Laboratories Revenue in Autoimmune Disease Diagnostics Business (2015-2020)
11.3.5 Bio-Rad Laboratories Recent Development
11.4 EUROIMMUN
11.4.1 EUROIMMUN Company Details
11.4.2 EUROIMMUN Business Overview
11.4.3 EUROIMMUN Autoimmune Disease Diagnostics Introduction
11.4.4 EUROIMMUN Revenue in Autoimmune Disease Diagnostics Business (2015-2020)
11.4.5 EUROIMMUN Recent Development
11.5 Inova Diagnostics
11.5.1 Inova Diagnostics Company Details
11.5.2 Inova Diagnostics Business Overview
11.5.3 Inova Diagnostics Autoimmune Disease Diagnostics Introduction
11.5.4 Inova Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2015-2020)
11.5.5 Inova Diagnostics Recent Development
11.6 Roche Diagnostics
11.6.1 Roche Diagnostics Company Details
11.6.2 Roche Diagnostics Business Overview
11.6.3 Roche Diagnostics Autoimmune Disease Diagnostics Introduction
11.6.4 Roche Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2015-2020)
11.6.5 Roche Diagnostics Recent Development
11.7 Siemens Healthcare
11.7.1 Siemens Healthcare Company Details
11.7.2 Siemens Healthcare Business Overview
11.7.3 Siemens Healthcare Autoimmune Disease Diagnostics Introduction
11.7.4 Siemens Healthcare Revenue in Autoimmune Disease Diagnostics Business (2015-2020)
11.7.5 Siemens Healthcare Recent Development
11.8 DiaSorin
11.8.1 DiaSorin Company Details
11.8.2 DiaSorin Business Overview
11.8.3 DiaSorin Autoimmune Disease Diagnostics Introduction
11.8.4 DiaSorin Revenue in Autoimmune Disease Diagnostics Business (2015-2020)
11.8.5 DiaSorin Recent Development
11.9 ERBA Diagnostics
11.9.1 ERBA Diagnostics Company Details
11.9.2 ERBA Diagnostics Business Overview
11.9.3 ERBA Diagnostics Autoimmune Disease Diagnostics Introduction
11.9.4 ERBA Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2015-2020)
11.9.5 ERBA Diagnostics Recent Development
11.10 Euro Diagnostica
11.10.1 Euro Diagnostica Company Details
11.10.2 Euro Diagnostica Business Overview
11.10.3 Euro Diagnostica Autoimmune Disease Diagnostics Introduction
11.10.4 Euro Diagnostica Revenue in Autoimmune Disease Diagnostics Business (2015-2020)
11.10.5 Euro Diagnostica Recent Development
11.11 Autoimmune Technologies
10.11.1 Autoimmune Technologies Company Details
10.11.2 Autoimmune Technologies Business Overview
10.11.3 Autoimmune Technologies Autoimmune Disease Diagnostics Introduction
10.11.4 Autoimmune Technologies Revenue in Autoimmune Disease Diagnostics Business (2015-2020)
10.11.5 Autoimmune Technologies Recent Development
11.12 Avant Diagnostics
10.12.1 Avant Diagnostics Company Details
10.12.2 Avant Diagnostics Business Overview
10.12.3 Avant Diagnostics Autoimmune Disease Diagnostics Introduction
10.12.4 Avant Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2015-2020)
10.12.5 Avant Diagnostics Recent Development
11.13 Exagen Diagnostics
10.13.1 Exagen Diagnostics Company Details
10.13.2 Exagen Diagnostics Business Overview
10.13.3 Exagen Diagnostics Autoimmune Disease Diagnostics Introduction
10.13.4 Exagen Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2015-2020)
10.13.5 Exagen Diagnostics Recent Development
11.14 Gold Standard Diagnostics
10.14.1 Gold Standard Diagnostics Company Details
10.14.2 Gold Standard Diagnostics Business Overview
10.14.3 Gold Standard Diagnostics Autoimmune Disease Diagnostics Introduction
10.14.4 Gold Standard Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2015-2020)
10.14.5 Gold Standard Diagnostics Recent Development
11.15 HOB Diagnostics
10.15.1 HOB Diagnostics Company Details
10.15.2 HOB Diagnostics Business Overview
10.15.3 HOB Diagnostics Autoimmune Disease Diagnostics Introduction
10.15.4 HOB Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2015-2020)
10.15.5 HOB Diagnostics Recent Development
11.16 HUMAN Diagnostics
10.16.1 HUMAN Diagnostics Company Details
10.16.2 HUMAN Diagnostics Business Overview
10.16.3 HUMAN Diagnostics Autoimmune Disease Diagnostics Introduction
10.16.4 HUMAN Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2015-2020)
10.16.5 HUMAN Diagnostics Recent Development
11.17 Immco Diagnostics
10.17.1 Immco Diagnostics Company Details
10.17.2 Immco Diagnostics Business Overview
10.17.3 Immco Diagnostics Autoimmune Disease Diagnostics Introduction
10.17.4 Immco Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2015-2020)
10.17.5 Immco Diagnostics Recent Development
11.18 ImmunArray
10.18.1 ImmunArray Company Details
10.18.2 ImmunArray Business Overview
10.18.3 ImmunArray Autoimmune Disease Diagnostics Introduction
10.18.4 ImmunArray Revenue in Autoimmune Disease Diagnostics Business (2015-2020)
10.18.5 ImmunArray Recent Development
11.19 Myriad Genetics
10.19.1 Myriad Genetics Company Details
10.19.2 Myriad Genetics Business Overview
10.19.3 Myriad Genetics Autoimmune Disease Diagnostics Introduction
10.19.4 Myriad Genetics Revenue in Autoimmune Disease Diagnostics Business (2015-2020)
10.19.5 Myriad Genetics Recent Development
11.20 Omega Diagnostics
10.20.1 Omega Diagnostics Company Details
10.20.2 Omega Diagnostics Business Overview
10.20.3 Omega Diagnostics Autoimmune Disease Diagnostics Introduction
10.20.4 Omega Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2015-2020)
10.20.5 Omega Diagnostics Recent Development
11.21 ORGENTEC Diagnostika
10.21.1 ORGENTEC Diagnostika Company Details
10.21.2 ORGENTEC Diagnostika Business Overview
10.21.3 ORGENTEC Diagnostika Autoimmune Disease Diagnostics Introduction
10.21.4 ORGENTEC Diagnostika Revenue in Autoimmune Disease Diagnostics Business (2015-2020)
10.21.5 ORGENTEC Diagnostika Recent Development
11.22 Phadia
10.22.1 Phadia Company Details
10.22.2 Phadia Business Overview
10.22.3 Phadia Autoimmune Disease Diagnostics Introduction
10.22.4 Phadia Revenue in Autoimmune Disease Diagnostics Business (2015-2020)
10.22.5 Phadia Recent Development
11.23 Protagen
10.23.1 Protagen Company Details
10.23.2 Protagen Business Overview
10.23.3 Protagen Autoimmune Disease Diagnostics Introduction
10.23.4 Protagen Revenue in Autoimmune Disease Diagnostics Business (2015-2020)
10.23.5 Protagen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Autoimmune Disease Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Analyzers
Table 4. Key Players of Assay Kits
Table 5. Global Autoimmune Disease Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 6. Global Autoimmune Disease Diagnostics Market Size by Regions (US$ Million): 2020 VS 2026
Table 7. Global Autoimmune Disease Diagnostics Market Size by Regions (2015-2020) (US$ Million)
Table 8. Global Autoimmune Disease Diagnostics Market Share by Regions (2015-2020)
Table 9. Global Autoimmune Disease Diagnostics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 10. Global Autoimmune Disease Diagnostics Market Share by Regions (2021-2026)
Table 11. Autoimmune Disease Diagnostics Market Market Trends
Table 12. Autoimmune Disease Diagnostics Market Drivers
Table 13. Autoimmune Disease Diagnostics Market Challenges
Table 14. Autoimmune Disease Diagnostics Market Restraints
Table 15. Global Autoimmune Disease Diagnostics Revenue by Players (2015-2020) (US$ Million)
Table 16. Global Autoimmune Disease Diagnostics Market Share by Players (2015-2020)
Table 17. Global Top Autoimmune Disease Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Autoimmune Disease Diagnostics as of 2019)
Table 18. Global Autoimmune Disease Diagnostics by Players Market Concentration Ratio (CR5 and HHI)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Autoimmune Disease Diagnostics Product Solution and Service
Table 21. Mergers & Acquisitions, Expansion Plans
Table 22. Global Autoimmune Disease Diagnostics Market Size by Type (2015-2020) (US$ Million)
Table 23. Global Autoimmune Disease Diagnostics Market Size Share by Type (2015-2020)
Table 24. Global Autoimmune Disease Diagnostics Revenue Market Share by Type (2021-2026)
Table 25. Global Autoimmune Disease Diagnostics Market Size Share by Application (2015-2020)
Table 26. Global Autoimmune Disease Diagnostics Market Size by Application (2015-2020) (US$ Million)
Table 27. Global Autoimmune Disease Diagnostics Market Size Share by Application (2021-2026)
Table 28. North America Autoimmune Disease Diagnostics Market Size by Type (2015-2020) (US$ Million)
Table 29. North America Autoimmune Disease Diagnostics Market Share by Type (2015-2020)
Table 30. North America Autoimmune Disease Diagnostics Market Size by Application (2015-2020) (US$ Million)
Table 31. North America Autoimmune Disease Diagnostics Market Share by Application (2015-2020)
Table 32. North America Autoimmune Disease Diagnostics Market Size by Country (US$ Million) (2015-2020)
Table 33. North America Autoimmune Disease Diagnostics Market Share by Country (2015-2020)
Table 34. Europe Autoimmune Disease Diagnostics Market Size by Type (2015-2020) (US$ Million)
Table 35. Europe Autoimmune Disease Diagnostics Market Share by Type (2015-2020)
Table 36. Europe Autoimmune Disease Diagnostics Market Size by Application (2015-2020) (US$ Million)
Table 37. Europe Autoimmune Disease Diagnostics Market Share by Application (2015-2020)
Table 38. Europe Autoimmune Disease Diagnostics Market Size by Country (US$ Million) (2015-2020)
Table 39. Europe Autoimmune Disease Diagnostics Market Share by Country (2015-2020)
Table 40. China Autoimmune Disease Diagnostics Market Size by Type (2015-2020) (US$ Million)
Table 41. China Autoimmune Disease Diagnostics Market Share by Type (2015-2020)
Table 42. China Autoimmune Disease Diagnostics Market Size by Application (2015-2020) (US$ Million)
Table 43. China Autoimmune Disease Diagnostics Market Share by Application (2015-2020)
Table 44. China Autoimmune Disease Diagnostics Market Size by Region (US$ Million) (2015-2020)
Table 45. China Autoimmune Disease Diagnostics Market Share by Region (2015-2020)
Table 46. Japan Autoimmune Disease Diagnostics Market Size by Type (2015-2020) (US$ Million)
Table 47. Japan Autoimmune Disease Diagnostics Market Share by Type (2015-2020)
Table 48. Japan Autoimmune Disease Diagnostics Market Size by Application (2015-2020) (US$ Million)
Table 49. Japan Autoimmune Disease Diagnostics Market Share by Application (2015-2020)
Table 50. Japan Autoimmune Disease Diagnostics Market Size by Country (US$ Million) (2015-2020)
Table 51. Japan Autoimmune Disease Diagnostics Market Share by Country (2015-2020)
Table 52. Southeast Asia Autoimmune Disease Diagnostics Market Size by Type (2015-2020) (US$ Million)
Table 53. Southeast Asia Autoimmune Disease Diagnostics Market Share by Type (2015-2020)
Table 54. Southeast Asia Autoimmune Disease Diagnostics Market Size by Application (2015-2020) (US$ Million)
Table 55. Southeast Asia Autoimmune Disease Diagnostics Market Share by Application (2015-2020)
Table 56. Southeast Asia Autoimmune Disease Diagnostics Market Size by Country (US$ Million) (2015-2020)
Table 57. Southeast Asia Autoimmune Disease Diagnostics Market Share by Country (2015-2020)
Table 58. Abbott Laboratories Company Details
Table 59. Abbott Laboratories Business Overview
Table 60. Abbott Laboratories Product
Table 61. Abbott Laboratories Revenue in Autoimmune Disease Diagnostics Business (2015-2020) (US$ Million)
Table 62. Abbott Laboratories Recent Development
Table 63. Beckman Coulter Company Details
Table 64. Beckman Coulter Business Overview
Table 65. Beckman Coulter Product
Table 66. Beckman Coulter Revenue in Autoimmune Disease Diagnostics Business (2015-2020) (US$ Million)
Table 67. Beckman Coulter Recent Development
Table 68. Bio-Rad Laboratories Company Details
Table 69. Bio-Rad Laboratories Business Overview
Table 70. Bio-Rad Laboratories Product
Table 71. Bio-Rad Laboratories Revenue in Autoimmune Disease Diagnostics Business (2015-2020) (US$ Million)
Table 72. Bio-Rad Laboratories Recent Development
Table 73. EUROIMMUN Company Details
Table 74. EUROIMMUN Business Overview
Table 75. EUROIMMUN Product
Table 76. EUROIMMUN Revenue in Autoimmune Disease Diagnostics Business (2015-2020) (US$ Million)
Table 77. EUROIMMUN Recent Development
Table 78. Inova Diagnostics Company Details
Table 79. Inova Diagnostics Business Overview
Table 80. Inova Diagnostics Product
Table 81. Inova Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2015-2020) (US$ Million)
Table 82. Inova Diagnostics Recent Development
Table 83. Roche Diagnostics Company Details
Table 84. Roche Diagnostics Business Overview
Table 85. Roche Diagnostics Product
Table 86. Roche Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2015-2020) (US$ Million)
Table 87. Roche Diagnostics Recent Development
Table 88. Siemens Healthcare Company Details
Table 89. Siemens Healthcare Business Overview
Table 90. Siemens Healthcare Product
Table 91. Siemens Healthcare Revenue in Autoimmune Disease Diagnostics Business (2015-2020) (US$ Million)
Table 92. Siemens Healthcare Recent Development
Table 93. DiaSorin Business Overview
Table 94. DiaSorin Product
Table 95. DiaSorin Company Details
Table 96. DiaSorin Revenue in Autoimmune Disease Diagnostics Business (2015-2020) (US$ Million)
Table 97. DiaSorin Recent Development
Table 98. ERBA Diagnostics Company Details
Table 99. ERBA Diagnostics Business Overview
Table 100. ERBA Diagnostics Product
Table 101. ERBA Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2015-2020) (US$ Million)
Table 102. ERBA Diagnostics Recent Development
Table 103. Euro Diagnostica Company Details
Table 104. Euro Diagnostica Business Overview
Table 105. Euro Diagnostica Product
Table 106. Euro Diagnostica Revenue in Autoimmune Disease Diagnostics Business (2015-2020) (US$ Million)
Table 107. Euro Diagnostica Recent Development
Table 108. Autoimmune Technologies Company Details
Table 109. Autoimmune Technologies Business Overview
Table 110. Autoimmune Technologies Product
Table 111. Autoimmune Technologies Revenue in Autoimmune Disease Diagnostics Business (2015-2020) (US$ Million)
Table 112. Autoimmune Technologies Recent Development
Table 113. Avant Diagnostics Company Details
Table 114. Avant Diagnostics Business Overview
Table 115. Avant Diagnostics Product
Table 116. Avant Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2015-2020) (US$ Million)
Table 117. Avant Diagnostics Recent Development
Table 118. Exagen Diagnostics Company Details
Table 119. Exagen Diagnostics Business Overview
Table 120. Exagen Diagnostics Product
Table 121. Exagen Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2015-2020) (US$ Million)
Table 122. Exagen Diagnostics Recent Development
Table 123. Gold Standard Diagnostics Company Details
Table 124. Gold Standard Diagnostics Business Overview
Table 125. Gold Standard Diagnostics Product
Table 126. Gold Standard Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2015-2020) (US$ Million)
Table 127. Gold Standard Diagnostics Recent Development
Table 128. HOB Diagnostics Company Details
Table 129. HOB Diagnostics Business Overview
Table 130. HOB Diagnostics Product
Table 131. HOB Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2015-2020) (US$ Million)
Table 132. HOB Diagnostics Recent Development
Table 133. HUMAN Diagnostics Company Details
Table 134. HUMAN Diagnostics Business Overview
Table 135. HUMAN Diagnostics Product
Table 136. HUMAN Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2015-2020) (US$ Million)
Table 137. HUMAN Diagnostics Recent Development
Table 138. Immco Diagnostics Company Details
Table 139. Immco Diagnostics Business Overview
Table 140. Immco Diagnostics Product
Table 141. Immco Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2015-2020) (US$ Million)
Table 142. Immco Diagnostics Recent Development
Table 143. ImmunArray Company Details
Table 144. ImmunArray Business Overview
Table 145. ImmunArray Product
Table 146. ImmunArray Revenue in Autoimmune Disease Diagnostics Business (2015-2020) (US$ Million)
Table 147. ImmunArray Recent Development
Table 148. Myriad Genetics Company Details
Table 149. Myriad Genetics Business Overview
Table 150. Myriad Genetics Product
Table 151. Myriad Genetics Revenue in Autoimmune Disease Diagnostics Business (2015-2020) (US$ Million)
Table 152. Myriad Genetics Recent Development
Table 153. Omega Diagnostics Company Details
Table 154. Omega Diagnostics Business Overview
Table 155. Omega Diagnostics Product
Table 156. Omega Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2015-2020) (US$ Million)
Table 157. Omega Diagnostics Recent Development
Table 158. ORGENTEC Diagnostika Company Details
Table 159. ORGENTEC Diagnostika Business Overview
Table 160. ORGENTEC Diagnostika Product
Table 161. ORGENTEC Diagnostika Revenue in Autoimmune Disease Diagnostics Business (2015-2020) (US$ Million)
Table 162. ORGENTEC Diagnostika Recent Development
Table 163. Phadia Company Details
Table 164. Phadia Business Overview
Table 165. Phadia Product
Table 166. Phadia Revenue in Autoimmune Disease Diagnostics Business (2015-2020) (US$ Million)
Table 167. Phadia Recent Development
Table 168. Protagen Company Details
Table 169. Protagen Business Overview
Table 170. Protagen Product
Table 171. Protagen Revenue in Autoimmune Disease Diagnostics Business (2015-2020) (US$ Million)
Table 172. Protagen Recent Development
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Autoimmune Disease Diagnostics Market Share by Type: 2020 VS 2026
Figure 2. Analyzers Features
Figure 3. Assay Kits Features
Figure 4. Global Autoimmune Disease Diagnostics Market Share by Application: 2020 VS 2026
Figure 5. Hospitals Case Studies
Figure 6. Diagnostic and Research Laboratories Case Studies
Figure 7. Autoimmune Disease Diagnostics Report Years Considered
Figure 8. Global Autoimmune Disease Diagnostics Market Size (US$ Million), YoY Growth 2015-2026
Figure 9. Global Autoimmune Disease Diagnostics Market Share by Regions: 2020 VS 2026
Figure 10. Global Autoimmune Disease Diagnostics Market Share by Regions (2021-2026)
Figure 11. Global Autoimmune Disease Diagnostics Market Share by Players in 2019
Figure 12. Global Top Autoimmune Disease Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Autoimmune Disease Diagnostics as of 2019
Figure 13. The Top 10 and 5 Players Market Share by Autoimmune Disease Diagnostics Revenue in 2019
Figure 14. North America Autoimmune Disease Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 15. United States Autoimmune Disease Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 16. Canada Autoimmune Disease Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 17. Europe Autoimmune Disease Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. Germany Autoimmune Disease Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. France Autoimmune Disease Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. U.K. Autoimmune Disease Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. Italy Autoimmune Disease Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. Russia Autoimmune Disease Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. Nordic Autoimmune Disease Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Rest of Europe Autoimmune Disease Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Asia-Pacific Autoimmune Disease Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. China Autoimmune Disease Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Japan Autoimmune Disease Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. South Korea Autoimmune Disease Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Southeast Asia Autoimmune Disease Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. India Autoimmune Disease Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Australia Autoimmune Disease Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Rest of Asia-Pacific Autoimmune Disease Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Latin America Autoimmune Disease Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Mexico Autoimmune Disease Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Brazil Autoimmune Disease Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Middle East & Africa Autoimmune Disease Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Turkey Autoimmune Disease Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Saudi Arabia Autoimmune Disease Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. UAE Autoimmune Disease Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Rest of Middle East & Africa Autoimmune Disease Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Abbott Laboratories Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2015-2020)
Figure 42. Beckman Coulter Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2015-2020)
Figure 43. Bio-Rad Laboratories Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2015-2020)
Figure 44. EUROIMMUN Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2015-2020)
Figure 45. Inova Diagnostics Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2015-2020)
Figure 46. Roche Diagnostics Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2015-2020)
Figure 47. Siemens Healthcare Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2015-2020)
Figure 48. DiaSorin Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2015-2020)
Figure 49. ERBA Diagnostics Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2015-2020)
Figure 50. Euro Diagnostica Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2015-2020)
Figure 51. Autoimmune Technologies Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2015-2020)
Figure 52. Avant Diagnostics Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2015-2020)
Figure 53. Exagen Diagnostics Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2015-2020)
Figure 54. Gold Standard Diagnostics Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2015-2020)
Figure 55. HOB Diagnostics Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2015-2020)
Figure 56. HUMAN Diagnostics Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2015-2020)
Figure 57. Immco Diagnostics Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2015-2020)
Figure 58. ImmunArray Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2015-2020)
Figure 59. Myriad Genetics Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2015-2020)
Figure 60. Omega Diagnostics Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2015-2020)
Figure 61. ORGENTEC Diagnostika Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2015-2020)
Figure 62. Phadia Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2015-2020)
Figure 63. Protagen Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2015-2020)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
  • Infectious Disease Diagnostics Market by Product & Service (Reagents, Kits), Test Type (Lab, PoC), Sample (Blood, Urine), Technology (Immunodiagnostics, NGS, PCR, ISH, INAAT), Disease (Hepatitis, HIV, HAI, HPV, Syphilis, TB, Flu) - Global Forecast to 2028
    Published: 10-Jan-2024        Price: US 4950 Onwards        Pages: 309
    “Rising focus on decentralized diagnostics is driving the overall growth of the infectious disease diagnostics market.” The infectious disease diagnostics market is valued at an estimated USD 21.4 billion in 2023 and is projected to reach USD 31.5 billion by 2028 at a CAGR of 8.0% during the forecast period. The rising focus on decentralized diagnostics and the growing demand for CLIA-waived PoC tests have driven the use of PoC technologies. The trend towa......
  • Global Pharmaceutical Testing Services Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 102
    Pharmaceutical Testing Service is often used to identify The chemical composition and molecular structure of each individual substance contained in a medication. This knowledge provides insight into a drug's performance and safety considerations. Pharmaceutical testing can reveal a pharmaceutical's solubility and can predict The medication's ability to reach a specific target within The body. Testing may even reveal contamination in The manufacturing production process or highlight other,......
  • Global Pharmaceutical Testing Services Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 156
    According to our LPI (LP Information) latest study, the global Pharmaceutical Testing Services market size was valued at US$ 3398.6 million in 2023. With growing demand in downstream market, the Pharmaceutical Testing Services is forecast to a readjusted size of US$ 7008.4 million by 2030 with a CAGR of 10.9% during review period. The research report highlights the growth potential of the global Pharmaceutical Testing Services market. Pharmaceutical Testing Services are expected to show ......
  • Global Helicobacter Pylori Diagnostics Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109
    According to our LPI (LP Information) latest study, the global Helicobacter Pylori Diagnostics market size was valued at US$ 624.1 million in 2023. With growing demand in downstream market, the Helicobacter Pylori Diagnostics is forecast to a readjusted size of US$ 1040.4 million by 2030 with a CAGR of 7.6% during review period. The research report highlights the growth potential of the global Helicobacter Pylori Diagnostics market. Helicobacter Pylori Diagnostics are expected to show st......
  • Global Laboratory-developed Testing Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 110
    According to our LPI (LP Information) latest study, the global Laboratory-developed Testing market size was valued at US$ 3442.2 million in 2023. With growing demand in downstream market, the Laboratory-developed Testing is forecast to a readjusted size of US$ 4512 million by 2030 with a CAGR of 3.9% during review period. The research report highlights the growth potential of the global Laboratory-developed Testing market. Laboratory-developed Testing are expected to show stable growth i......
  • Global Laboratory-developed Testing Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 109
    According to our (Global Info Research) latest study, the global Laboratory-developed Testing market size was valued at USD 3620.6 million in 2023 and is forecast to a readjusted size of USD 4649.1 million by 2030 with a CAGR of 3.6% during review period. Twenty-five years ago, the Food and Drug Administration (FDA) asserted in a draft document that "home brew" tests-now commonly referred to as laboratory-developed tests (LDTs)-are subject to the same regulatory oversight as other in vit......
  • Global Pharmaceutical Testing Services Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 151
    According to our (Global Info Research) latest study, the global Pharmaceutical Testing Services market size was valued at USD 3574.8 million in 2023 and is forecast to a readjusted size of USD 6987.8 million by 2030 with a CAGR of 10.0% during review period. Pharmaceutical Testing Service is often used to identify the chemical composition and molecular structure of each individual substance contained in a medication. This knowledge provides insight into a drug's performance and s......
  • Global TB Diagnostic Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 116
    Market Overview of Global TB Diagnostic market: According to our latest research, the global TB Diagnostic market looks promising in the next 5 years. As of 2022, the global TB Diagnostic market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global TB Diagnostic market, with a sys......
  • IVD Products - Global Market Insights and Sales Trends 2024
    Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 124
    This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for IVD Products, with both quantitative a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs